Resistance Potential of the HLA-A2-restricted Immunodominant SARS-CoV-2 Specific CD8+ T Cell Receptor Repertoire to Antigenic Drift
RNA-seq (gene expression) · human · 30 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 30 samples: 30 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Resistance potential of the HLA-A2-restricted immunodominant SARS-CoV-2-specific CD8(+) T cell receptor repertoire to antigenic driftNature communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE246491_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1033336 and SRA study SRP468999. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 30 sample titles: 30 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7869775 Chip_1, mRNA+Abseq+ST
- GSM7869776 Chip_1, TCR
- GSM7869777 Chip_1, Tetramer
- GSM7869778 Chip_2, Tetramer
- GSM7869779 Chip_2, mRNA+Abseq+ST
- GSM7869780 Chip_2, TCR
- GSM7869781 Chip_3, mRNA+Abseq+ST
- GSM7869782 Chip_3, Tetramer
- GSM7869783 Chip_3, TCR
- GSM7869784 Chip_4, mRNA+Abseq+ST
- GSM7869785 Chip_4, Tetramer
- GSM7869786 Chip_4, TCR
- GSM7869787 Chip_5, mRNA+Abseq+ST
- GSM7869788 Chip_5, Tetramer
- GSM7869789 Chip_5, TCR
- GSM7869790 Chip_6, mRNA+Abseq+ST
- GSM7869791 Chip_6, Tetramer
- GSM7869792 Chip_6, TCR
- GSM7869793 TCRa, DonorB, Cells 1-48
- GSM7869794 TCRa, DonorB, Cells 48-96
- GSM7869795 TCRb, DonorB, Cells 1-48
- GSM7869796 TCRb, DonorB, Cells 48-96
- GSM8516560 TCRa, ND602, Cells 1-48
- GSM8516561 TCRa, ND602, Cells 49-96
- GSM8516562 TCRb, ND602, Cells 1-48
- GSM8516563 TCRb, ND602, Cells 49-96
- GSM8516564 TCRa, ND580, Cells 1-48
- GSM8516565 TCRa, ND580, Cells 49-96
- GSM8516566 TCRb, ND580, Cells 1-48
- GSM8516567 TCRb, ND580, Cells 49-96
- GSE210231 CD8+ T cell memory induced by successive SARS-CoV-2 mRNA vaccinations is characterized by shifts in clonal dominance 931 samples shares sars-cov-2, cd8
- GSE303324 SARS-CoV-2 Variant Boosters and Breakthrough Infections Drive Functional Differences in the Memory B Cell Repertoire 55 samples shares sars-cov-2, repertoire
- GSE288581 Single Cell Immune Profiling in Ankylosing Spondylitis Reveals Resistance of CD8+ T cells to Immune Exhaustion 30 samples shares cd8, resistance
- GSE291537 Epigenetically controlled ZEB2 expression promotes the cytotoxic potential of CMV-specific CD8+ T cells 12 samples shares cd8, potential
- GSE272993 Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 T cells [dataset 1] 360 samples shares cd8
- GSE225063 Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity 256 samples shares cd8
- GSE288199 Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies 180 samples shares cd8
- GSE288856 Clonal CD8+ T Cells Populate the Leptomeninges and Coordinate with Immune Cells in Human Degenerative Brain Diseases 113 samples shares cd8
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.